15-12B 1 h89008e15-12b.txt PARACELSUS HEALTHCARE CORPORATION 1 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTION 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number: 001-12055 PARACELSUS HEALTHCARE CORPORATION (By event of statutory merger, Paracelsus Healthcare Corporation is now Clarent Hospital Corporation) --------------------------------------------------------------------- (Exact name of registrant as specified in its charter) 515 W. Greens Road, Suite 500, Houston, Texas --------------------------------------------------------------------- (Address, including zip code, and telephone number, including area code, of registrant's principal executive offices) 10% Senior Subordinated Notes Due August 15, 2006 Paracelsus Healthcare Common Stock, no stated value --------------------------------------------------------------------- (Title of each class of securities covered by this Form) None --------------------------------------------------------------------- (Titles of all other classes of securities for which a duty to file reports under section 13(a) or 15(d) remains) Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports: Rule 12g-4(a)(1)(i) [X] Rule 12h-3(b)(1)(i) [X] Rule 12g-4(a)(1)(ii) [ ] Rule 12h-3(b)(1)(ii) [ ] Rule 12g-4(a)(2)(i) [ ] Rule 12h-3(b)(2)(i) [ ] Rule 12g-4(a)(2)(ii) [ ] Rule 12h-3(b)(2)(ii) [ ] Rule 15d-6 [X] Approximate number of holders of record as of the certification or notice date: 0 2 Pursuant to the requirements of the Securities Exchange Act of 1934 Paracelsus Healthcare Corporation has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person. Date: July 9, 2001 By: /S/ Lawrence A. Humphrey ------------------------ Lawrence A. Humphrey Executive Vice President, & Chief Financial Officer